ArticleBMC cancer2022

A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study.

Yong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.